Cochlear Limited revised earnings guidance for the full year 2020. The company now expects to deliver underlying net profit of $270 million - 290 million, a 2-9% increase on underlying net profit for full year 2019. The guidance outlook was reduced from $290 million - 300 million on 11 February due to an expected impact from the novel coronavirus (2019-nCoV). While the business is delivering strong results from the cochlear implant business, profit growth will be lower than original expectations due to the impact of the coronavirus on sales in Greater China.